Guillain-Barré syndrome in the northern area of Gran Canaria and the island of Lanzarote;Síndrome de Guillain-Barré en el área norte de Gran Canaria e isla de Lanzarote

Revista de Neurologia

Volumn 35, Issue 8, 2002, Pages 705-710

  Aladro Benito, Yolanda ^a   Conde Sendin M A ^a   Munoz Fernandez C ^a   Perez Correa S ^a   Alemany Rodriguez M J ^a   Fiuza Perez ^a   Alamo Santana F ^a  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

Canary Islands; Clinical features; Evolution; Guillain Barr syndrome; Incidence

Indexed keywords

ADULT; ARTICLE; ASSISTED VENTILATION; CLINICAL FEATURE; ELECTROPHYSIOLOGY; EVOKED MUSCLE RESPONSE; EVOLUTION; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOMODULATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; ADOLESCENT; AGED; ARTIFICIAL VENTILATION; ATLANTIC ISLANDS; BLOOD; CHILD; DIAPHRAGM PARALYSIS; HOSPITALIZATION; INFANT; METABOLISM; MIDDLE AGED; PARALYSIS; POSTOPERATIVE COMPLICATION; PREGNANCY; PREGNANCY COMPLICATION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; REVIEW; SEASON; VIRUS INFECTION;

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ATLANTIC ISLANDS; CHILD; CHILD, PRESCHOOL; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PARALYSIS; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; RESPIRATION, ARTIFICIAL; RESPIRATORY PARALYSIS; RETROSPECTIVE STUDIES; SEASONS; SEVERITY OF ILLNESS INDEX; VIRUS DISEASES;

EID: 1842848019     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3508.2002352     Document Type: Article

References (41)

1. Amason GBW, Soliven B. Acute inflammatory demyelinating polyneuropathy. In Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral neuropathy. Philadelphia: Saunders; 1993. p. 1437-97.
2. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré Syndrome. Philadelphia: FA Davis Company; 1991.
3. Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986; 109: 1115-26.
4. Griffin JW, Li CY, Ho TW, Xue P, Macko C, Gao CY, et al. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995; 118: 577-95.
5. Griffin JW, Li CY, Ho TW, Tian M, Gao CY, Xue P, et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol 1996; 39: 17-28.
6. Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immunopathogenesis and treatment of the Guillain-Barré syndrome. Part I. Muscle Nerve 1995; 18: 137-53.
7. Winer JB, Hughes RAC, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1988; 51: 605-12.
8. Mckhann GM, Griffin JW, Comblath DR, Mellits ED, Fisher RS, Quaskey SA, et al. Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol 1988; 23: 347-53.
9. Visser LH, Schmitz PIM, Meulstee J, van Doom PA, van der Meché FGA. Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange. Neurology 1999; 53: 598-604.
10. Raphael JC, Masson C, Morice V, Brunel D, Gajdos PH, Barois A, et al. Le syndrome de Landry-Guillain-Barré. Etude des facteurs prognostiques dans 223 cas. Rev Neurol (Paris) 1986; 142: 613-24.
11. Miller RG, Peterson GW, Daube JR, Albers JW. Prognostic value of electrodiagnosis in Guillain-Barré syndrome. Muscle Nerve 1988; 11: 769-74.
12. Comblath DR, Mellits ED, Griffin JW, Mckhann GM, Albers JW, Miller RG, et al. Motor conduction studies in Guillain-Barré syndrome: description and prognostic value. Ann Neurol 1988; 23: 354-9.
13. The Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985; 35: 1096-104.
14. French Cooperative Group on Plasma Exchange morbidity in Guillain-Barré Syndrome: efficiency of plasma exchange in Guillain-Barré syndrome: Role of replacement fluids. Ann Neurol 1987; 22: 753-61.
15. Van der Meché FGA, Schmitz PIM, Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992; 326: 1123-9.
16. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997; 349: 225-30.
17. Rees JH, Thompson RD, Smeeton NC, Hughes RAC. Epidemiological study of Guillain-Barré syndrome in south east England. J Neurol Neurosurg Psychiatry 1998; 64: 74-7.
18. Sedano MJ, Calleja J, Canga E, Berciano J. Guillain-Barré Syndrome in Cantabria, Spain. An epidemiological and clinical study. Acta Neurol Scand 1994; 89: 287-92.
19. Matias-Guiu J, Martin R, Blanquer J, González MJ, Falip R, Oltra A, et al. Incidence of Guillain-Barré syndrome and ganglioside intake in Alcoy. Spain. Neuroepidemiology 1993; 12: 58-60.
20. Cuadrado JI, de Pedro-Cuesta J, Ara JR, Cemillan CA, Diaz M, Duarte J, et al. Guillain-Barré syndrome in Spain, 1985-1997: epidemiological and public health views. Eur Neurol 2001; 46: 83-91.
21. Cheng Q, Jiang GX, Fredrikson S, Link H, de Pedro-Cuesta J. Incidence of Guillain-Barré Syndrome in Sweden 1996. Eur J Neurol 2000; 7: 11-6.
22. van Koningsveld R, van Doom PA, Schmitz PI, Ang CW, van der Meche FG. Mild forms of Guillain-Barré syndrome in an epidemiologic survey in the Netherlands. Neurology 2000; 54: 620-5.
23. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology. A prospective study on the incidence and prognosis of Guillain-Barré syndrome in Emilia-Romagna region, Italy (1992-1993). Neurology 1997; 48: 214-21.
24. Jiang G-X, de Pedro-Cuesta J, Fredrikson S. Guillain-Barré syndrome in South-West Stockholm, 1973-1991. Quality of registered hospital diagnoses and incidence. Acta Neurol Scand 1995; 91: 109-17.
25. Halls J, Bredkjaer C, Friis ML. Guillain-Barré syndrome: diagnostic criteria, epidemiology, clinical course and prognosis. Acta Neurol Scand 1988; 78: 118-22.
26. National Institute of Neurologic and Communicative Disorders and Stroke Ad Hoc Committee: Criteria for diagnosis of Guillain-Barré syndrome. Ann Neurol 1978; 3: 565-6.
27. Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial of prednisolone in acute polyneuropathy. Lancet 1978; 2: 750-3.
28. Asbury AK, Comblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990; 27 (Suppl): S21-4.
29. Hadden RDM, Comblath DR, Hughes RAC, Zielasek J, Hartung HP, Toyka KV, et al. Electrophysiological classification of Guillain-Barré Syndrome: clinical associations and outcome. Ann Neurol 1998; 44: 780-8.
30. Lyu RK, Tang LM, Cheng SY, Hsu WC, Chen ST. Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry 1997; 63: 494-500.
31. McLean M, Duclos, Jacob P, Humphreys P. Incidence of Guillain-Barré syndrome in Ontario and Quebec, 1983-1989, using hospital service databases. Epidemiology 1994; 5: 443-8.
32. Winner SJ, Evans JG. Age-specific incidence of Guillain-Barré syndrome in Oxfordshire. Quart J Med 1990; 77: 1297-304.
33. Larsen JP, Kvale G, Nyland H. Epidemiology of the Guillain-Barré syndrome in the county of Hordeland western Norway. Acta Neurol Scand 1985; 71: 43-7.
34. Howlett WP, Vedeler CA, Nyland H, Aarli JA. Guillain-Barré syndrome in norther Tanzania: a comparison of epidemiological and clinical findings with western Norway. Acta Neurol Scand 1996; 93: 44-9.
35. Visser LH, Van der Meché FGA, Meulstee J, Rothbarth P, Jacobs BC, Schmitz PIM, et al. Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Neurology 1996; 47: 668-73.
36. Winer JB, Hughes RAC, Anderson MJ, Jones DM, Kangro H, Watkins RPF. A prospective study of acute idiopathic neuropathy II. Antecedent events. J Neurol Neurosurg Psychiatry 1988; 51: 613-8.
37. Rees JH, Soudain SE, Gregson NA, Hughes ARC. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995; 333: 1374-9.
38. Enders U, Karch H, Toyka K, Michels M, Zielasek J, Pette M, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann Neurol 1993; 34: 136-44.
39. Gibbels E, Giebisch U. Natural course of acute and chronic monophasic inflammatory demyelinating polyneuropathies (IDP). A restrospective analysis of 266 cases. Acta Neurol Scand 1992; 85: 282-91.
40. Meulstee J, van der Meché FGA, and the Dutch Guillain-Barré Study Group. Electrodiagnostic criteria for polyneuropathy and demyelination: application in 135 patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1995; 59: 482-6.
41. Cheng Q, Jiang GX, Press R, Andersson M, Ekstedt B, Vrethem M, et al. Clinical epidemiology of Guillain-Barré syndrome in adults in Sweden 1996-97: a prospective study. Eur J Neurol 2000; 7: 685-92.